Verdence Capital Advisors LLC Raises Position in Agilent Technologies, Inc. $A

Verdence Capital Advisors LLC grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 5.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,818 shares of the medical research company’s stock after purchasing an additional 86 shares during the period. Verdence Capital Advisors LLC’s holdings in Agilent Technologies were worth $215,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Stone House Investment Management LLC purchased a new stake in shares of Agilent Technologies during the 1st quarter valued at $30,000. Ransom Advisory Ltd purchased a new position in Agilent Technologies in the 1st quarter worth $32,000. Central Pacific Bank Trust Division purchased a new position in Agilent Technologies in the 2nd quarter worth $33,000. Zions Bancorporation National Association UT purchased a new position in Agilent Technologies in the 1st quarter worth $38,000. Finally, Costello Asset Management INC purchased a new position in Agilent Technologies in the 1st quarter worth $47,000.

Agilent Technologies Price Performance

Shares of A opened at $141.14 on Friday. The business’s 50-day moving average is $127.03 and its two-hundred day moving average is $117.63. The company has a market capitalization of $40.01 billion, a P/E ratio of 33.13, a P/E/G ratio of 4.56 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same period last year, the firm earned $1.32 EPS. The company’s quarterly revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on A. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research note on Wednesday, October 8th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Rothschild & Co Redburn began coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 target price for the company. TD Cowen raised their target price on Agilent Technologies from $150.00 to $162.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Robert W. Baird increased their price target on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.